Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul;9(4):297-303.
doi: 10.1177/1756285616637046. Epub 2016 Mar 10.

Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic deterioration

Christiane Schneider-Gold  1 , Marco Krenzer  1 , Erdmute Klinker  2 , Behrouz Mansouri-Thalegani  2 , Wolfgang Müllges  1 , Klaus V Toyka  1 , Ralf Gold  3
Affiliations

Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic deterioration

Christiane Schneider-Gold et al. Ther Adv Neurol Disord. 2016 Jul.

Abstract

Objectives: The goal of this study was to analyze safety and assess the efficacy of standard plasma exchange (PE) compared with immunoadsorption (IA) alone, or an alternating combination of both in deteriorating myasthenia gravis (MG).

Methods: A total of 72 patients with MG who had received PE procedures for treatment of severe deterioration were retrospectively analyzed. They received either five cycles of PE (1-1.5 plasma volumes), or five cycles of IA in line with plasma separation, or a sequential alternating procedure of one cycle of PE followed by two cycles of IA, which was repeated once or more if needed.

Results: A total of 19 patients received PE, 24 patients IA, and 29 the alternating combination therapy. All groups were equally distributed by sex and mean MG score before treatment. The number of treatment cycles and days on therapy did not differ between the groups. Mean MG scores at discharge were 3.0 (PE), 1.8 (IA) and 1.6 (combination) (p = 0.028 for combination versus PE). Inpatient time was 30.7 days (PE), 22.3 days (IA) and 20.0 days in combination therapy (p < 0.05 for combination versus PE). Side effects such as allergic reactions or hypocoagulability were significantly more frequent in the PE group (37% in PE versus 4% in IA and 3.6% in the alternating combination, p < 0.05).

Conclusion: Semiselective IA in combination with PE, and to a lesser extent IA alone, was associated with a shorter hospital stay and more pronounced reduction of the MG score than PE.

Keywords: immunoadsorption; myasthenia gravis; myasthenic crisis; plasma exchange; therapy.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Besinger U., Toyka K., Hömberg M., Heininger K., Hohlfeld R., Fateh-Moghadam A. (1983) Myasthenia gravis: Long term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology 33: 1316–1321. - PubMed
    1. Clauss A. (1957) Rapid physiological coagulation method in determination of fibronogen. Acta Haematol 17: 237–246. - PubMed
    1. Dalakas M. and Medscape (2011) Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol 7: 507–517. - PubMed
    1. Gajdos P., Chevret S., Clair B., Tranchant C., Chastang C. (1997) Clinical trial of plasma exchange and high dose immunoglobulin in myasthenia gravis. Ann Neurology 41: 789–796. - PubMed
    1. Haas M., Mayr N., Zeitlhofer J., Goldammer A., Derfler K. (2002) Long-term treatment of myasthenia gravis with immunoadsorption. J Clin Apher 17: 847. - PubMed